Sensydia announced today that it completed enrollment in its 225-subject development study for its AI-powered Cardiac Performance System (CPS). Los Angeles-based Sensydia designed the AI-based, non-invasive CPS to use heart sound analysis. It may enable earlier detection and improved therapy guidance for heart failure and pulmonary hypertension patients. CPS uses ultra-sensitive biosensors for the rapid, […]
Sensydia
Sensydia wins FDA breakthrough nod to expand uses for its cardiac monitoring device
Sensydia announced today that it received FDA breakthrough device designation for its Cardiac Performance System (CPS). Los Angeles-based Sensydia designed CPS as a non-invasive cardiac monitoring device that reports critical heart performance measurements to physicians for the comprehensive evaluation of patients with advanced and persistent heart failure. It can make the measurements without an in-hospital […]